Andrea Park / Fierce Biotech:

Boston-based Beta Bionics, whose automated insulin dosing software the FDA approved in May 2023, raised a $100M Series D, taking its total funding to $293.5M  —  In the wake of earning FDA clearance for its insulin pump an |  In the wake of earning FDA clearance for its insulin pump …

Andrea Park / Fierce Biotech:

Boston-based Beta Bionics, whose automated insulin dosing software the FDA approved in May 2023, raised a $100M Series D, taking its total funding to $293.5M  —  In the wake of earning FDA clearance for its insulin pump an |  In the wake of earning FDA clearance for its insulin pump …

Source: TechMeme
Source Link: http://www.techmeme.com/230901/p11#a230901p11